Page 38 - Read Online
P. 38

Page 2 of 14           Nakamoto et al. Plast Aesthet Res 2024;11:54  https://dx.doi.org/10.20517/2347-9264.2024.82

               pathways was measured by reverse transcription and quantitative polymerase chain reaction (RT-qPCR).

               Results: The epithelialization rate on Day 14 was significantly higher in the treatment group. The days that the
               epithelialization rate exceeded 85%, 90%, and 95% were significantly shorter in the treatment group. There was
               no significant difference in wound blood flow or RNA abundance related to TGFβ, EMT, or MFA-related pathways
               among the groups at any time point.

               Conclusion: The results demonstrate that the beta-blocker timolol accelerates epithelialization of mesh skin
               grafted full-thickness burn wounds through a mechanism other than improving wound blood flow.
               Keywords: Beta-blocker, wound healing, burn, mesh skin graft




               INTRODUCTION
               Despite numerous studies and developments in burn treatment, limited donor skin and delayed wound
               healing are still major problems. Surgical treatment for burns generally involves the removal of eschar and
                                        [1,2]
               skin graft for wound closure . In large burns, donor skin is frequently limited, and often the skin is
               meshed to be grafted. The higher the mesh ratio, the greater the area that can be covered. However, this
                                                                                        [1,3]
               increases the area of mesh gaps, so epithelialization of the mesh gap takes longer . Additionally, the
               closure of meshes is delayed due to complications such as infection, hematoma, or other factors, even if the
               wounds are covered with sufficient autologous skin. The longer epithelialization is delayed, the greater the
               risk for skin and soft tissue infection, the reduced quality of life for patients, and the increased cost of
               care . Therefore, safer, more effective, readily available, and more cost-effective interventions that
                   [2]
               accelerate epithelialization of mesh gaps and raw surface areas due to graft loss are very valuable.

               Wound healing includes hemostasis, inflammation, proliferation, and tissue remodeling phases . Among
                                                                                                 [4]
               these, keratinocyte migration during the proliferation phase is crucial for effective wound epithelialization.
               Keratinocytes, located in the epidermis, play an important role in skin barrier function. Adrenergic
               receptors expressed on keratinocytes are mainly beta-2 receptors , and several response systems triggered
                                                                      [5-7]
               by stimulation of the receptors have been shown to reduce the migration ability of keratinocytes .
                                                                                                       [6-8]
               Endogenous adrenaline, which decreases the migration ability of keratinocytes, has been reported to cause
                                   [7]
               delayed wound healing . Conversely, beta-adrenergic receptor blockers increase the migration ability of
               keratinocytes.


               Beta-adrenergic receptor blockers are drugs that act on beta receptors in the sympathetic nervous system
               and inhibit their activation. Beta-blockers are used orally or intravenously for hypertension and tachycardia,
               as eye drops for glaucoma, and recently for the treatment of infantile hemangiomas orally and topically. In
               severe burns, beta-blockers have been used as an intravenous therapy to reduce inflammation, resting
               energy expenditure, and hypermetabolism . Timolol is a beta-adrenergic receptor antagonist and is used as
                                                   [9]
                                         [10]
               an eye drop to treat glaucoma . Previous studies have demonstrated that timolol can be safely applied
               topically to promote wound healing .
                                             [8]
               In recent years, some studies have demonstrated the efficacy of beta-blockers in wound healing.  Previous
               studies have reported that beta-blocker infusion promotes epithelialization of flame burns in murine
                                                                                            [11]
               models , and that topical timolol improves wound healing of thermal burns in rat models . Additionally,
                     [7]
               the topical application of timolol with dermal matrix, preconditioned human mesenchymal stem cells
               promotes wound healing of the total skin defect wound in porcine models , and the topical application of
                                                                              [12]
               timolol promotes the epithelialization of donor wound of split-thickness skin graft in human . However,
                                                                                               [13]
   33   34   35   36   37   38   39   40   41   42   43